D'iberville Chiropractic Clinic, Inc. | |
10317 C Boney Ave., D'iberville, MS 39540-4836 | |
(228) 392-4664 | |
(228) 392-4664 |
Full Name | D'iberville Chiropractic Clinic, Inc. |
---|---|
Type | Facility |
Speciality | Chiropractor |
Location | 10317 C Boney Ave., D'iberville, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568472215 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
D'iberville Chiropractic Clinic, Inc. 10317 C Boney Ave., D'iberville, MS 39540-4836 Ph: (228) 392-4664 | D'iberville Chiropractic Clinic, Inc. 10317 C Boney Ave., D'iberville, MS 39540-4836 Ph: (228) 392-4664 |
News Archive
A bad hangover usually comes with a variety of symptoms like headaches, fatigue, upset stomach, sweating, nausea, bad taste in the mouth excessive thirst, sensitivity to light etc. This is mainly due to the diuretic effects of alcohol that leaves one dehydrated.
Data from two Phase III studies of Merck's investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.
The risk for developing osteonecrosis of the jaw after a tooth extraction is significantly higher among patients who receive bisphosphonates than those who do not, suggest study findings.
International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCorâ„¢" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.
Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredictâ„¢ Genetic Risk Test for periodontal disease.
› Verified 8 days ago